You are here:Home
»
Antibodies
»
Abs to Infectious Disease WNV
»
Anti -West Nile Virus, Matrix (West Nile Virus Matrix Protein, WNV Matrix Protein, West Nile Virus Small Envelope Protein M)
Anti -West Nile Virus, Matrix (West Nile Virus Matrix Protein, WNV Matrix Protein, West
Nile Virus Small Envelope Protein M)
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| Clone |
Host |
Grade |
Applications |
| Polyclonal |
Rabbit |
Affinity Purified |
B IP IH IC IF |
|
| West Nile (WN), the most widespread among flaviviruses, was first isolated from the serum of a febrile woman in 1937 in the West Nile district ofuganda. West Nile virus was first detected in North America in 1999 and has subsequently spread throughout the United States and Canada and into Mexico and the Caribbean. In Africa, southern Europe, western Asia, and the United States, WNV has been isolated from mosquitoes of more than 40 species. In the United States, Canada, and Israel, WNV is responsible for significant avian mortality. | | | Catalog # | W1018-52G | | Applications | Suitable for use in Immunofluorescence, Western Blot, Immunohistochemistry, Immunoprecipitation and Immunocytochemistry. Other applications not tested. | | Recommended Dilution | Immunofluorescence: 1-2ug/ml | | Western Blot: 0.5-2ug/ml | | Immunohistochemistry (paraffin): 1ug/ml | | Immunocytochemistry: 1-2ug/ml | | Optimal dilutions to be determined by the researcher. | | Positive Control | West Nile virus infected cell lysate | | Storage and Stability | May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. | | CAS Number | n/a | | Clone Type | Polyclonal | | Isotype | IgG | | Host | Rabbit | | Concentration | ~0.5mg/ml | | Form | Supplied as a liquid in PBS, 0.05% BSA, 0.05% sodium azide. | | Purity | Purified by Protein G affinity chromatography. | | Immunogen | Synthetic peptide corresponding to amino acid residues 8-27 (GESTLANKKGAWLDSTKATR) of West Nile Virus glycoprotein M. | | Specificity | Recognizes West Nile Virus glycoprotein M WNV M. | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
External Links
|
